Want to join the conversation?
During 3Q15, $ECL's adjusted EPS, excluding special gains and charges and discrete tax items from both years, increased 6% to $1.28, despite an $0.11 or 9% headwind from currencies and pension. This growth was driven by fixed currency sales gains, delivered product and other cost savings, synergies, new products, & a lower tax rate and share count.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)